首页> 外文OA文献 >PCV50 UP-TITRATION OF STATIN THERAPY TO MEET CANADIAN TARGET LIPID GOALS: ECONOMIC IMPACT OFTITRATION ASSOCIATED WITH COMPARATIVE EFFICACY OF ROSUVASTATIN, ATORVASTATIN, SIMVASTATIN AND PRAVASTATIN

【2h】

PCV50 UP-TITRATION OF STATIN THERAPY TO MEET CANADIAN TARGET LIPID GOALS: ECONOMIC IMPACT OFTITRATION ASSOCIATED WITH COMPARATIVE EFFICACY OF ROSUVASTATIN, ATORVASTATIN, SIMVASTATIN AND PRAVASTATIN

机译：他汀类药物治疗的PCV 50上调以满足加拿大目标脂类目标：滴定的经济影响与罗伐他汀，阿托伐他汀，辛伐他汀和普伐他汀的比较功效相关

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Frial T; Beamer B; Costa-Scharplatz M;
展开▼
作者单位

展开▼
年度 2008
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献

1. Comparison of the efficacy of rosuvastatin versus atorvastatin, simvastatin, and pravastatin in achieving lipid goals: results from the STELLAR trial. [J] . McKenney JM, Jones PH, Adamczyk MA, Current medical research and opinion . 2003,第8期

机译：罗苏伐他汀与阿托伐他汀，辛伐他汀和普伐他汀在达到脂质目标方面的功效比较：STELLAR试验的结果。
2. Comparison of rosuvastatin with atorvastatin, simvastatin and pravastatin in achieving cholesterol goals and improving plasma lipids in hypercholesterolaemic patients with or without the metabolic syndrome in the MERCURY I trial. [J] . Stender S, Schuster H, Barter P, Diabetes, obesity & metabolism . 2005,第4期

机译：在MERCURY I试验中，比较瑞舒伐他汀与阿托伐他汀，辛伐他汀和普伐他汀在达到胆固醇目标和改善血浆胆固醇水平的高胆固醇血症患者中是否存在代谢综合征的比较。
3. More Western hypercholesterolemic patients achieve Japan Atherosclerosis Society LDL-C goals with rosuvastatin therapy than with atorvastatin, pravastatin, or simvastatin therapy. [J] . Strutt K, Caplan R, Hutchison H, Circulation journal . 2004,第2期

机译：与阿托伐他汀，普伐他汀或辛伐他汀治疗相比，使用瑞舒伐他汀治疗的西方高胆固醇血症患者达到日本动脉粥样硬化学会LDL-C目标的比例更高。
4. Clinical and economic impact of statin therapy compliance on hyperlipidemic patients with concomitant CHD risk factors. [D] . Samant, Navendu Dinanath. 2010

机译：他汀类药物治疗依从性对伴有冠心病危险因素的高脂血症患者的临床和经济影响。
5. Changes in LDL-C levels and goal attainment associated with addition of ezetimibe to simvastatin atorvastatin or rosuvastatin compared with titrating statin monotherapy [O] . JoAnne M Foody, Peter P Toth, Joanne E Tomassini, 2013

机译：与滴定他汀单一疗法相比辛伐他汀阿托伐他汀或瑞舒伐他汀添加依泽替米贝相关的LDL-C水平和目标达成的变化
6. PCV6 A META-ANALYSIS OF EFFICACY OF ATORVASTATIN IN COMPARISON TO PRAVASTATIN, SIMVASTATIN AND ROSUVASTATIN FOR THE CONTROL OF DYSLIPIDEMIA AND CARDIOVASCULAR EVENTS PREVENTION [O] . Villasis-Keever MA, Rendón-Masías ME, Pineda-Cruz R, 2010

机译：PCV6与普伐他汀，辛伐他汀和罗伐他汀比较，阿托伐他汀与血脂异常和心血管疾病预防的功效的元分析

PCV50 UP-TITRATION OF STATIN THERAPY TO MEET CANADIAN TARGET LIPID GOALS: ECONOMIC IMPACT OFTITRATION ASSOCIATED WITH COMPARATIVE EFFICACY OF ROSUVASTATIN, ATORVASTATIN, SIMVASTATIN AND PRAVASTATIN

著录项

相似文献

相关主题

期刊订阅